March 05, 2015 2:52 AM ET

Capital Markets

Company Overview of CHL Healthcare Partners

Executive Profile

Ronald W. Lennox

Former Director, Amicus Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 9 different industries.

See Board Relationships


Dr. Ronald W. Lennox, also known as Ron, was the Founding Chief Executive Officer at Protometrix, Inc. and CGI Pharmaceuticals, Inc. Dr. Lennox was a Partner at GeneOhm Sciences, Inc., CHL Healthcare Partners, CHL Medical Partners II, L.P. and CHL Medical Partners III, L.P. He founded GeneOhm Sciences, Inc. in 1997 and invested in the biotechnology and molecular diagnostic sectors. Prior to CHL, he was a General Partner at Hancock Venture Partners and was responsible ...

Corporate Headquarters

1055 Washington Boulevard
Stamford, Connecticut 06901

United States

Phone: 203-324-7700
Fax: 203-324-3636

Board Members Memberships

Former Director
Former Director
Former Member of the Board
Former Director


University of Pennsylvania - The Wharton School
Unknown/Other Education
University of Glasgow Scotland
University of Oxford

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHL Healthcare Partners, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at